The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight

Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects

(2022) Yixin Hu et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Determination of Abiraterone and Its Metabolites in Human Serum by LC-ESI-TOF/MS Using Solid-phase Extraction

(2021) Hiromi KANJI et al.   ANALYTICAL SCIENCES

AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants

(2021) Bikash Ranjan JENA et al.   Turkish Journal of Pharmaceutical Sciences

A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer

(2018) Juana Rodriguez et al.   Current Pharmaceutical Analysis

Identification, Characterization and High-Performance Liquid Chromatography Quantification for Process-Related Impurities in Abiraterone Acetate Bulk Drug

(2018) Changjie Hu et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry

(2018) Atul Bhatnagar et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column

(2017) Mohammad Alyamani et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma

(2017) Merel van Nuland et al.   THERAPEUTIC DRUG MONITORING

A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer

(2015) Tiphaine Belleville et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

β-cyclodextrin Sensitized Spectrofluorimetry for the Determination of Abiraterone Acetate and Abiraterone

(2013) Aiqin Gong et al.   JOURNAL OF FLUORESCENCE

CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents

(2013) Lina Yin et al.   Nature Reviews Urology

Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats

(2012) S. Vijay Kumar et al.   BIOMEDICAL CHROMATOGRAPHY

Analysis of abiraterone stress degradation behavior using liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry

(2012) Alaa Khedr et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE